Thermo Fisher price target raised to $81 from $70 at RW Baird Baird raised its price target on Thermo Fisher following better than expected Q4 results. The firm cited strong organic growth, conservative guidance, and the potential for accretive acquisitions and stock buybacks. Shares are Outperform rated.
News For TMO From The Last 14 Days
Check below for free stories on TMO the last two weeks.
Thermo Fisher to sell Cole-Palmer to GTCR for $480M in cash Thermo Fisher Scientific has signed a definitive agreement to sell its Cole-Parmer channel business to private equity firm GTCR, LLC for $480M in cash. Thermo Fisher anticipates closing the transaction in Q3, subject to customary closing conditions and applicable regulatory approvals. The company expects an immaterial impact to 2014 adjusted EPS and will update annual guidance in its Q2 earnings release on July 23.